-
Something wrong with this record ?
Does ibuprofen affect the expression of alginate genes in pathogenic Pseudomonas aeruginosa strains
N. Babaei, B. Rasti, H. Zamani
Language English Country United States
Document type Journal Article
- MeSH
- Alginates MeSH
- Anti-Bacterial Agents metabolism pharmacology MeSH
- Biofilms MeSH
- Cystic Fibrosis * microbiology MeSH
- Ibuprofen metabolism pharmacology MeSH
- Humans MeSH
- Pseudomonas Infections * drug therapy microbiology MeSH
- Pseudomonas aeruginosa MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Conversion to mucoid form is a crucial step in the pathogenesis of P. aeruginosa in burns and cystic fibrosis (CF) patients. Alginate is considered the major component of biofilm and is highly associated with the formation of mucoid biofilm in this species. Nonsteroid anti-inflammatory drugs (NSAIDs), including ibuprofen, have shown promising antibacterial and antibiofilm potential for bacterial pathogens. In this study, we aimed to evaluate the effect of ibuprofen on the expression of alginate synthetase (alg8), GDP-mannose dehydrogenase (algD), and alginate lyase (algL) genes in multiple drug-resistant (MDR) P. aeruginosa strains. The biofilm formation potential and the expression of alg8, algD, and algL among the bacteria treated with ibuprofen (at sub-inhibitory concentration) were investigated using the crystal violet staining and real-time PCR assays, respectively. The minimum inhibitory concentration of ibuprofen for the studied strains was determined 1024-2048 μg/mL. We observed that ibuprofen was able to reduce bacterial biofilm by 51-77%. Also, the expression of alg8, algD, and algL decreased by 32, 52, and 48%, respectively. The reduction of the genes responsible for alginate synthesis indicates promising antivirulece potential of ibuprofen to combat P. aeruginosa infection, especially in burns and CF patients. Our findings suggest that ibuprofen could be used to reduce the pathogenicity of P. aeruginosa that could be used in combination with antibiotics to treat drug-resistant infections.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22020224
- 003
- CZ-PrNML
- 005
- 20240416152337.0
- 007
- ta
- 008
- 220802s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-022-00962-9 $2 doi
- 035 __
- $a (PubMed)35325409
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Babaei, Nastaran $u Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Guilan, Iran
- 245 10
- $a Does ibuprofen affect the expression of alginate genes in pathogenic Pseudomonas aeruginosa strains / $c N. Babaei, B. Rasti, H. Zamani
- 520 9_
- $a Conversion to mucoid form is a crucial step in the pathogenesis of P. aeruginosa in burns and cystic fibrosis (CF) patients. Alginate is considered the major component of biofilm and is highly associated with the formation of mucoid biofilm in this species. Nonsteroid anti-inflammatory drugs (NSAIDs), including ibuprofen, have shown promising antibacterial and antibiofilm potential for bacterial pathogens. In this study, we aimed to evaluate the effect of ibuprofen on the expression of alginate synthetase (alg8), GDP-mannose dehydrogenase (algD), and alginate lyase (algL) genes in multiple drug-resistant (MDR) P. aeruginosa strains. The biofilm formation potential and the expression of alg8, algD, and algL among the bacteria treated with ibuprofen (at sub-inhibitory concentration) were investigated using the crystal violet staining and real-time PCR assays, respectively. The minimum inhibitory concentration of ibuprofen for the studied strains was determined 1024-2048 μg/mL. We observed that ibuprofen was able to reduce bacterial biofilm by 51-77%. Also, the expression of alg8, algD, and algL decreased by 32, 52, and 48%, respectively. The reduction of the genes responsible for alginate synthesis indicates promising antivirulece potential of ibuprofen to combat P. aeruginosa infection, especially in burns and CF patients. Our findings suggest that ibuprofen could be used to reduce the pathogenicity of P. aeruginosa that could be used in combination with antibiotics to treat drug-resistant infections.
- 650 _2
- $a algináty $7 D000464
- 650 _2
- $a antibakteriální látky $x metabolismus $x farmakologie $7 D000900
- 650 _2
- $a biofilmy $7 D018441
- 650 12
- $a cystická fibróza $x mikrobiologie $7 D003550
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ibuprofen $x metabolismus $x farmakologie $7 D007052
- 650 12
- $a pseudomonádové infekce $x farmakoterapie $x mikrobiologie $7 D011552
- 650 _2
- $a Pseudomonas aeruginosa $7 D011550
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rasti, Behnam $u Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Guilan, Iran
- 700 1_
- $a Zamani, Hojjatolah $u Department of Biology, Faculty of Science, University of Guilan, Guilan, Iran. h_Zamani@guilan.ac.ir $1 https://orcid.org/0000000216224530
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 67, č. 4 (2022), s. 617-623
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35325409 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220802 $b ABA008
- 991 __
- $a 20240416152334 $b ABA008
- 999 __
- $a ok $b bmc $g 1845877 $s 1171470
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 67 $c 4 $d 617-623 $e 20220324 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20220802